Glycos Biotechnologies
International biochemical company commercializing sustainable chemicals made from renewable feedstocks.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 Valuation: €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | $1.1m | Late VC |
| Total Funding | 000k | ||
Related Content
Glycos Biotechnologies is a life sciences company focused on developing engineered lipid-based technologies to enhance the delivery and performance of natural bioactive molecules. The company's research and development efforts are centered on creating solutions for the nutritional and therapeutic industries.
GlycosBio has developed a library of "Activated Oil Systems" designed to selectively target harmful pathogens while preserving beneficial bacteria, which has applications in skincare and microbiota research. Additionally, the company designs personalized nutritional lipid systems to improve the bioavailability of essential nutrients and building blocks for the body. Their business model appears to be B2B, collaborating with medical professionals and scientific advisors to design these systems for therapeutic and over-the-counter (OTC) skincare products as well as nutritional supplements. The company serves clients in the pharmaceutical, cosmetic, and food science sectors.
Keywords: lipid engineering, bioactive molecules, nutritional supplements, therapeutic delivery, skincare, microbiota, bioavailability, food science, pathogens, drug delivery